(Q34487166)

2 August 2017

0 references

1 reference

title

Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea (English)

1 reference

2 August 2017

0 references

0 references

0 references

1 reference

Saccharomyces boulardii

object named as

Saccharomyces boulardii

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216624%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

M Kołodziej

2

0 references

language of work or name

English

0 references

publication date

27 July 2015

1 reference

Alimentary Pharmacology & Therapeutics

2 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216624%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216624%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216624%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

page(s)

793-801

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216624%20AND%20SRC:MED&resulttype=core&format=json

Clinical practice. Antibiotic-associated diarrhea

15 June 2020

cites work

1 reference

Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study

21 January 2018

1 reference

Antibiotic-associated diarrhoea

21 January 2018

1 reference

Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease

21 January 2018

1 reference

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

21 January 2018

1 reference

Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

GRADE guidelines: 2. Framing the question and deciding on important outcomes.

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.

21 January 2018

1 reference

The probiotic effect of Saccharomyces boulardii in a pediatric age group

21 January 2018

1 reference

Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Prevention and treatment of diarrhoea with Saccharomyces boulardii in children with acute lower respiratory tract infections

21 January 2018

1 reference

Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.

21 January 2018

1 reference

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

21 January 2018

1 reference

Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication

21 January 2018

1 reference

The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori

21 January 2018

1 reference

The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children

21 January 2018

1 reference

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients

21 January 2018

1 reference

Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders

21 January 2018

1 reference

Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice

21 January 2018

1 reference

Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis

21 January 2018

1 reference

Inhibition of in vitro cell adherence of Clostridium difficile by Saccharomyces boulardii

21 January 2018

1 reference

Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis

21 January 2018

1 reference

Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections

21 January 2018

1 reference

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

21 January 2018

1 reference

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

21 January 2018

1 reference

Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.13344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26216624%20AND%20SRC:MED&resulttype=core&format=json

15 June 2020

1 reference